Publication | Open Access

Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties

Occupational ToxicologyEndocrine DisruptorsChemical SafetyPatient SafetyPharmacologyBenefit-risk AssessmentToxicologyCertain Medical DevicesEnvironmental Risk AssessmentEnvironmental ToxicologyMedicineHuman BiomonitoringHuman Safety Assessment